IBDEI2N0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44259,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,44259,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,44259,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,44260,0)
 ;;=R97.2^^200^2224^27
 ;;^UTILITY(U,$J,358.3,44260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44260,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,44260,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,44260,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,44261,0)
 ;;=R80.1^^200^2224^87
 ;;^UTILITY(U,$J,358.3,44261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44261,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,44261,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,44261,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,44262,0)
 ;;=R80.0^^200^2224^85
 ;;^UTILITY(U,$J,358.3,44262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44262,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,44262,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,44262,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,44263,0)
 ;;=R80.8^^200^2224^88
 ;;^UTILITY(U,$J,358.3,44263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44263,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,44263,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,44263,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,44264,0)
 ;;=R80.3^^200^2224^84
 ;;^UTILITY(U,$J,358.3,44264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44264,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,44264,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,44264,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,44265,0)
 ;;=R80.9^^200^2224^89
 ;;^UTILITY(U,$J,358.3,44265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44265,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,44265,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,44265,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,44266,0)
 ;;=Z87.442^^200^2224^77
 ;;^UTILITY(U,$J,358.3,44266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44266,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,44266,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,44266,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,44267,0)
 ;;=N18.1^^200^2224^13
 ;;^UTILITY(U,$J,358.3,44267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44267,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,44267,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,44267,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,44268,0)
 ;;=N18.2^^200^2224^14
 ;;^UTILITY(U,$J,358.3,44268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44268,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,44268,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,44268,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,44269,0)
 ;;=N18.3^^200^2224^15
 ;;^UTILITY(U,$J,358.3,44269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44269,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,44269,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,44269,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,44270,0)
 ;;=N18.4^^200^2224^16
 ;;^UTILITY(U,$J,358.3,44270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44270,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,44270,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,44270,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,44271,0)
 ;;=N18.5^^200^2224^17
 ;;^UTILITY(U,$J,358.3,44271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44271,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,44271,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,44271,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,44272,0)
 ;;=Q61.3^^200^2224^80
 ;;^UTILITY(U,$J,358.3,44272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44272,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,44272,1,4,0)
 ;;=4^Q61.3
